Sarigianni M. , Bekiari E., Tsapas A., et al. Effect of epinephrine and insulin resistance on human monocytes obtained from lean and obese healthy subjects: a pilot study. Angiology. 2010. IN PRESS.
2.
Sarigianni M. , Bekiari E., Tsapas A., et al. Effect of leptin and insulin resistance on properties of human monocytes in lean and obese healthy subjects. Angiology. 2010. IN PRESS.
3.
Sarigianni M. , Bekiari E., Tsapas A., et al. Effect of glucose and insulin on oxidized low density lipoprotein phagocytosis by human monocytes: A pilot study. Angiology. 2010. IN PRESS.
4.
Sarigianni M. , Tsapas A., Mikhailidis DP, et al. Involvement of signaling molecules on Na+/H+ exchanger-1 activity in human monocytes. Open Cardiovasc Med J.2010. IN PRESS.
5.
Russell JC, Proctor SD, Kelly SE, Löhn M., Busch AE, Schäfer S.Insulin-sensitizing and cardiovascular effects of the sodium-hydrogen exchange inhibitor, cariporide, in the jcr: La-cp rat and db/db mouse . J Cardiovasc Pharmacol. 2005;46(6):746-753.
6.
Finucane FM, Luan J., Wareham NJ, et al. Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia.2009;52(11):2345-2349.
7.
Paraskevas KI , Liapis CD, Mikhailidis DPLeptin: a promising therapeutic target with pleiotropic action besides body weight regulation. Curr Drug Targets. 2006;7(6):761-771.
8.
Cook JR, Semple RKHypoadiponectinemia-cause or consequence of human ‘‘Insulin resistance"?J Clin Endocrinol Metab. 2010;95(4):1544-1554.
9.
Li S., Shin HJ, Ding EL, van Dam RMAdiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis . JAMA.2009;302(2):179-188.
